Letters

Pharmacological heterogeneity limits antidepressant study

BMJ 2003; 327 doi: http://dx.doi.org/10.1136/bmj.327.7409.289-a (Published 31 July 2003) Cite this as: BMJ 2003;327:289

This article has a correction. Please see:

  1. Anthony S Hale, professor of psychiatry ([email protected])
  1. University of Kent, Canterbury CT2 7NZ

    EDITOR—MacGillivray et al potentially make a huge contribution to the understanding of the relative utility of selective serotonin reuptake inhibitors and older antidepressants in the treatment of depression in primary care.1 However, the usefulness of their meta-analysis is limited by the original data, as is so often the case.

    These results …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe